What are you looking for? Search Common searches: Intranet, Contact, Map, Professionals, Teaching units, Research groups, Fulltext search Tipus de contingut Professionals Projects Teaching Units Collaborating entities News Activities - Any - Search News Dr. Patricia Pozo Rosich participates in a series of articles on migraine published in The Lancet The publications review the socioeconomic impact of migraine and the diagnostic and therapeutic advances in this field. News Great participation of professionals from Vall d'Hebron in the 2nd National Congress of COVID-19 14 health professionals and researchers are speakers or moderators of round tables to analyze the impact of COVID-19 from different perspectives. News A pioneering study by Vall d'Hebron demonstrates the efficacy of a new recovery protocol for patients with advanced ovarian cancer The Enhanced Recovery After Surgery (ERAS) protocol allows patients undergoing surgery for advanced ovarian cancer to be discharged from hospital up to 2 days earlier and decrease their readmission rate. News Vall d'Hebron participates in the CombivacS clinical trial that will evaluate a second dose of the Pfizer vaccine to people already vaccinated with a dose of AstraZeneca The trial aims to provide scientific evidence to support decision-making regarding a possible alternative to complete immunization in people under 60 vaccinated with a dose of AstraZeneca. News An international study involving Vall d’Hebron shows that COVID-19 increases the risk of complications during pregnancy The INTERCOVID project finds that infected women are 50% more likely to have complications during pregnancy. News Vall d'Hebron begins two clinical trials to test a new system to filter blood and improve the evolution of COVID-19 and sepsis Seraph 100 consists of a filter capable of binding and eliminating microorganisms in the blood of patients who have an infection. The clinical trials that are now underway will study whether this system can reduce the severity of critical patients with COVID-19 and sepsis. News Dr. Joan Comella is appointed treasurer of ICORD and Dr. Mireia del Toro joins the board International Conference of Rare Diseases and Orphan Drugs (ICORD) is a world reference organization in rare diseases. News Vall d'Hebron participates in a study that identifies 33 new genetic variants associated with bipolar disorder These findings open the way for research into new therapeutic targets, as well as for the study of the possibility of reusing drugs that are already used in other illnesses for the treatment of bipolar disorder. News Vall d’Hebron identifies memory immune cells in blood and lungs essential for the control of SARS-CoV-2 Researchers have found lung-resident memory T lymphocytes months after SARS-CoV-2 infection, which would rapidly activate in the event of possible reinfection. News Vall d’Hebron has reached a record number of clinical trials despite the pandemic 2020 ended with the highest number of clinical trials recorded at the Vall d’Hebron Campus, which includes the Vall d'Hebron Research Institute (VHIR) and the Vall d'Hebron Institute of Oncology (VHIO): 1,365 active and 319 new. Pagination Previous page ‹‹ Page 55 Next page ››